金城医药：子公司收到药品注册证书

Core Viewpoint - Jincheng Pharmaceutical announced that its subsidiary, Guangdong Jincheng Jinsu Pharmaceutical Co., Ltd., has received a drug registration certificate for Morpholine Nitrozole Sodium Injection from the National Medical Products Administration [2] Group 1 - The announcement was made on the evening of October 20 [2] - The drug registration certificate is a significant regulatory milestone for the company [2] - This development may enhance the product portfolio and market presence of Jincheng Pharmaceutical [2]